エアロゾル薬物送達装置の市場規模、シェア、動向分析レポート：タイプ別、用途別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

エアロゾル薬剤送達装置市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のエアロゾル薬剤送達装置市場規模は2030年までに621億米ドルに達すると予測されています。

同市場は、2025～2030年にかけて13.16％の注目すべきCAGRで拡大すると予測されています。市場成長を促進する主要要因には、呼吸器疾患の有病率の上昇、医療意識の高まり、吸入器技術の進歩、在宅治療の需要拡大などがあります。

市場成長の原動力は、COPD、喘息、嚢胞性線維症などの呼吸器疾患の有病率の増加、携帯型吸入装置への注目の高まり、迅速で効果的な治療へのニーズなどです。その他の要因としては、政府の啓発キャンペーン、人口の高齢化、技術の進歩、機器の普及率向上、都市化、公害、研究開発の増加などが挙げられます。

市場開拓のイノベーションは、エコフレンドリー燃料の開発、患者のアドヒアランス向上のためのユーザーインターフェースデザインの改善、個別化診断と治療のためのAIの活用に重点が置かれています。生分解性材料の調査により、機器構造のサステイナブル代替案が提供される可能性があります。市場は競争が激しく細分化されており、急速な技術進歩が絶え間ない変化を促しています。企業は積極的に動向を取り入れ、患者中心でエコフレンドリーソリューションに注力し、成長機会を掴んでいます。

さらに、AptarGroup, Inc.、Koninklijke Philips N.V.、AstraZeneca、Novartis AGなどの主要企業は、市場での地位を強化するため、提携、共同研究、新製品の発売、買収、事業拡大などの戦略的取り組みを行っています。例えば、2024年1月、Kindeva薬物送達は、経鼻薬物送達を専門とするSummit Biosciencesの買収を発表しました。

経鼻薬物送達は、急性期や緊急時に非侵襲的に薬剤を投与することができるため、多くの適応症で好まれる投与形態になりつつあります。サミットは、経鼻送達用に薬剤を効果的に配合する方法と、商業規模で製造する能力に関する差別化された理解をもたらします。今回の買収は、薬剤と装置の組み合わせによるCDMO市場の世界リーダーになるというKindevaの野心に合致するだけでなく、患者の転帰と治療経験の改善を支援するために、当社が顧客に提供できるツールボックスを世界的に拡大するものです。

キンデバCEOミルトン・ボワイエ

エアロゾル薬物送達装置市場レポートハイライト

• 製品タイプ別では、吸入器市場が2024年の収益シェア89.59%で市場を独占し、技術的に先進的な製品開発の進展と医療セグメントにおけるデジタルソリューションの採用拡大により、予測期間中CAGRで最速の成長が見込まれます。
• 用途別では、COPDセグメントが2024年に最大の市場シェアを占め、世界の有病率の上昇により予測期間中に最も急成長すると予測されています。
• 流通チャネル別では、施設薬局セグメントが2024年に最大の市場シェアを占め、大量薬剤流通のニーズの高まりと呼吸器疾患の患者人口の拡大がその要因となっています。
• 北米は2024年に39.49％の市場シェアを占め、エアロゾル薬剤送達装置産業を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 エアロゾル薬物送達装置市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 産業分析
  • ユーザーの視点分析
  • 主要エンドユーザー
• 技術展望
• 規制の枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 産業の課題と機会の分析
• エアロゾル薬物送達装置市場分析ツール
  • ポーターの分析
  • PESTEL分析
• COVID-19の影響

第4章 エアロゾル薬物送達装置市場：タイプ別、推定・動向分析

• 定義と範囲
• タイプ別市場シェア分析、2024年と2030年
• セグメントダッシュボード
• エアロゾル薬物送達装置市場：タイプ別、2018～2030年
  • ネブライザー
  • 吸入器

第5章 エアロゾル薬物送達装置市場：用途別、推定・動向分析

• 定義と範囲
• 用途市場シェア分析、2024年と2030年
• セグメントダッシュボード
• エアロゾル薬物送達装置市場：用途別、2018～2030年
  • 喘息
  • 慢性閉塞性肺疾患（COPD）

第6章 エアロゾル薬物送達装置市場：流通チャネル別、推定・動向分析

• 定義と範囲
• 流通チャネル市場シェア分析、2024年と2030年
• セグメントダッシュボード
• エアロゾル薬物送達装置市場：流通チャネル別、2018～2030年
  • 小売薬局
  • 医療機関薬局
  • オンライン薬局

第7章 エアロゾル薬物送達装置市場：地域、タイプ、用途、流通チャネルによる地域別、推定・動向分析

• 定義と範囲
• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• エアロゾル薬物送達装置市場シェア、地域別、2024年と2030年、100万米ドル
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • デンマーク
  • ノルウェー
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業の市場シェア分析
• 企業ヒートマップ分析
• 戦略マッピング
  • 拡大
  • 合併と買収
  • パートナーシップとコラボレーション
  • 新製品の発売
  • 研究開発
• 企業プロファイル
  • AptarGroup, Inc.
  • Koninklijke Philips NV
  • AstraZeneca
  • Novartis AG
  • Sanofi
  • OMRON Corporation
  • Medline Industries, LP.
  • GF Health Products, Inc.
  • DRIVE MEDICAL GMBH & CO. KG
  • Teva Pharmaceutical Industries Ltd
  • Aerogen（Stamford Devices Limited Group）
  • Sensirion AG
  • PARI Respiratory Equipment, Inc.
  • Catalent, Inc
  • Pfizer Inc.
  • Beurer GmbH

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 North America aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 4 North America aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 5 North America aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 6 U.S. aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 7 U.S. aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 8 U.S. aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 9 Canada aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 10 Canada aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 11 Canada aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 12 Mexico aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 13 Mexico aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 14 Mexico aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 15 Europe aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 16 Europe aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 17 Europe aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 18 UK aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 19 UK aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 20 UK aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 21 Germany aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 22 Germany aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 23 Germany aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 24 France aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 25 France aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 26 France aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 27 Italy aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 28 Italy aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 29 Italy aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 30 Spain aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 31 Spain aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 32 Spain aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 33 Sweden aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 34 Sweden aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 35 Sweden aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 36 Denmark aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 37 Denmark aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 38 Denmark aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 39 Norway aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 40 Norway aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 41 Norway aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 45 Japan aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 46 Japan aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 47 Japan aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 48 China aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 49 China aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 50 China aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 51 India aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 52 India aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 53 India aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 54 Australia aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 55 Australia aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 56 Australia aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 57 South Korea aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 58 South Korea aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 59 Thailand aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 60 Thailand aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 61 Thailand aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 62 Latin America aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 63 Latin America aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 64 Latin America aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 65 Brazil aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 66 Brazil aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 67 Brazil aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 68 Argentina aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 69 Argentina aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 70 Argentina aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 71 MEA aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 72 MEA aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 73 MEA aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 74 South Africa aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 75 South Africa aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 76 South Africa aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 77 Saudi Arabia aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 78 Saudi Arabia aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 79 Saudi Arabia aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 80 UAE aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 81 UAE aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 82 UAE aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
• Table 83 Kuwait aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
• Table 84 Kuwait aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
• Table 85 Kuwait aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 List of Figures
• Fig. 2 Aerosol Drug Delivery Devices Market Segmentation
• Fig. 3 Information Procurement
• Fig. 4 Data Analysis Models
• Fig. 5 Market Formulation and Validation
• Fig. 6 Data Validating & Publishing
• Fig. 7 Market Snapshot
• Fig. 8 Segment Snapshot (1/2)
• Fig. 9 Segment Snapshot (2/2)
• Fig. 10 Competitive Landscape Snapshot
• Fig. 11 Aerosol Drug Delivery Devices- Market Size and Growth Prospects (USD Million)
• Fig. 12 Aerosol Drug Delivery Devices Market: Industry Value Chain Analysis
• Fig. 13 Aerosol Drug Delivery Devices Market: Market Dynamics
• Fig. 14 Aerosol Drug Delivery Devices Market: PORTER's Analysis
• Fig. 15 Aerosol Drug Delivery Devices Market: PESTEL Analysis
• Fig. 16 Aerosol Drug Delivery Devices Market: Type movement analysis, 2018-2030 (USD Million)
• Fig. 17 Aerosol Drug Delivery Devices Market Share Analysis by Type, 2024 & 2030
• Fig. 18 Nebulizers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 19 Jet Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 20 Mesh Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 21 Active Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 22 Passive Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 23 Ultrasonic Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 24 Inhaler Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 25 Pressurized Metered-Dose Inhaler (PDMI) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 26 Dry-Powder Inhaler (DPI) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 27 Aerosol Drug Delivery Devices Market: Application movement analysis, 2018-2030 (USD Million)
• Fig. 28 Aerosol Drug Delivery Devices Market Share Analysis by Application , 2024 & 2030
• Fig. 29 Asthma Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 30 Chronic Obstructive Pulmonary Disease (COPD) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 31 Cystic Fibrosis Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 32 Other (Pulmonary Arterial Hypertension (PAH), etc.) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 33 Aerosol Drug Delivery Devices Market: Distribution Channel Movement Analysis, 2018-2030 (USD Million)
• Fig. 34 Aerosol Drug Delivery Devices Market Share Analysis by Distribution Channel, 2024 & 2030
• Fig. 35 Retail Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 36 Institutional Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 37 Online Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 38 Aerosol Drug Delivery Devices Market Revenue, by Region, 2024 & 2030, (USD Million)
• Fig. 39 Regional Marketplace: Key Takeaways
• Fig. 40 North America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 U.S. Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Mexico Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Europe Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 UK Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
• Fig. 46 Germany Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
• Fig. 47 France Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
• Fig. 48 Italy Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
• Fig. 49 Spain Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
• Fig. 50 Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
• Fig. 51 Denmark Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
• Fig. 52 Norway Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
• Fig. 53 Asia Pacific Aerosol Drug Delivery Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 54 Japan Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 China Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 India Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Australia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Thailand Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Latin America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Brazil Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Argentina Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 MEA Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Saudi Arabia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 South Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Kuwait Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key Company Categorization
• Fig. 68 Company Market Positioning
• Fig. 69 Key Company Market Share Analysis, 2024
• Fig. 70 Strategic Framework

Aerosol Drug Delivery Devices Market Growth & Trends:

The global aerosol drug delivery devices market size is anticipated to reach USD 62.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 13.16% from 2025 to 2030. Major factors driving the market growth include the rising prevalence of respiratory diseases, increasing healthcare awareness, advancements in inhaler technology, and the growing demand for home-based treatments.

The market growth is driven by the increasing prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis, a growing focus on portable inhalation devices, and the need for quick, effective treatments. Other factors include government awareness campaigns, an aging population, technological advancements, higher device adoption, urbanization, pollution, and increased R&D.

Innovation in the market focuses on developing eco-friendly fuels, improving user-interface designs for better patient adherence, and using AI for personalized diagnostics and treatment. Research into biodegradable materials could provide sustainable alternatives for device construction. The market is competitive and fragmented, with rapid technological progress driving constant change. Companies proactively embrace trends, focusing on patient-centered, environmentally friendly solutions to seize growth opportunities.

Moreover, key players in the market, such as AptarGroup, Inc., Koninklijke Philips N.V., AstraZeneca, and Novartis AG, among others, are engaging in strategic initiatives such as partnerships, collaborations, new product launches, acquisitions, and expansions to strengthen their market position. For instance, in January 2024, Kindeva Drug Delivery announced the acquisition of Summit Biosciences, a company specializing in intranasal drug delivery.

"Nasal drug delivery is becoming a preferred dosage format for a growing number of indications, as it allows users to non-invasively administer medications in an acute or emergency setting. Summit brings a differentiated understanding of how to effectively formulate drugs for nasal delivery and the capability to manufacture them at commercial scale. This addition not only fits Kindeva's ambition to be a global leader in the drug-device combination products CDMO market but also expands the toolbox we can offer our customers to help improve patient outcomes and experience of care globally."

Kindeva CEO Milton Boyer.

Aerosol Drug Delivery Devices Market Report Highlights:

• Based on type, the inhaler segment dominated the market with a revenue share of 89.59% in 2024 and is expected to witness the fastest growth at a CAGR over the forecast period owing to the advancement the development of technologically advanced products, and the growing adoption of digital solutions in the healthcare sector.
• Based on application, the COPD segment held the largest market share in 2024 and is anticipated to be the fastest-growing segment over the forecast period owing to the rising increasing prevalence worldwide.
• Based on the distribution channel, the institutional pharmacies segment held the largest market share in 2024, driven by the increasing need for bulk medication distribution, and the expanding patient population with respiratory conditions.
• North America dominated the aerosol drug delivery devices industry with a market share of 39.49% in 2024, owing to the advanced healthcare infrastructure, increasing geriatric population, and technological advancements.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.1.2. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. Application Outlook
  • 2.2.3. Distribution Channel Outlook
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Aerosol Drug Delivery Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Industry Analysis
  • 3.2.1. User Perspective Analysis
  • 3.2.2. Key End Users
• 3.3. Technology Outlook
• 3.4. Regulatory Framework
• 3.5. Market Dynamics
  • 3.5.1. Market Drivers Analysis
    • 3.5.1.1. Rising prevalence of respiratory diseases
    • 3.5.1.2. Technological advancements
    • 3.5.1.3. Rising geriatric population
    • 3.5.1.4. Increasing awareness of self-medication and home healthcare
  • 3.5.2. Market Restraints Analysis
    • 3.5.2.1. High cost of devices
  • 3.5.3. Industry Challenges and Opportunity Analysis
• 3.6. Aerosol Drug Delivery Devices Market Analysis Tools
  • 3.6.1. Porter's Analysis
    • 3.6.1.1. Bargaining power of the suppliers
    • 3.6.1.2. Bargaining power of the buyers
    • 3.6.1.3. Threats of substitution
    • 3.6.1.4. Threats from new entrants
    • 3.6.1.5. Competitive rivalry
  • 3.6.2. PESTEL Analysis
    • 3.6.2.1. Political landscape
    • 3.6.2.2. Economic and Social landscape
    • 3.6.2.3. Technological landscape
    • 3.6.2.4. Environmental landscape
    • 3.6.2.5. Legal Landscape
• 3.7. Impact of COVID-19

Chapter 4. Aerosol Drug Delivery Devices Market: Type Estimates & Trend Analysis

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Aerosol Drug Delivery Devices Market: By Type, 2018 to 2030
  • 4.4.1. Nebulizers
    • 4.4.1.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2. Jet
      • 4.4.1.2.1. Jet Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.3. Mesh
      • 4.4.1.3.1. Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.4. Active
      • 4.4.1.4.1. Active Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.5. Passive
      • 4.4.1.5.1. Passive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.6. Ultrasonic
      • 4.4.1.6.1. Ultrasonic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Inhaler
    • 4.4.2.1. Inhaler Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.2. Pressurized Metered-Dose Inhaler (PMDI)
      • 4.4.2.2.1. Pressurized Metered-Dose Inhaler (PMDI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.3. Dry-Powder Inhaler (DPI)
      • 4.4.2.3.1. Dry-Powder Inhaler (DPI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Aerosol Drug Delivery Devices Market: Application Estimates & Trend Analysis

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Aerosol Drug Delivery Devices Market: By Application, 2018 to 2030
  • 5.4.1. Asthma
    • 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Chronic Obstructive Pulmonary Disease (COPD)
    • 5.4.2.1. Chronic Obstructive Pulmonary Disease (COPD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Aerosol Drug Delivery Devices Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Definition and Scope
• 6.2. Distribution Channel Market Share Analysis, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. Aerosol Drug Delivery Devices Market: By Distribution Channel, 2018 to 2030
  • 6.4.1. Retail Pharmacies
    • 6.4.1.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Institutional Pharmacies
    • 6.4.2.1. Institutional Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Online Pharmacies
    • 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Aerosol Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Region, Type, Application, Distribution Channel

• 7.1. Definition and Scope
• 7.2. Regional Market Share Analysis, 2024 & 2030
• 7.3. Regional Market Dashboard
• 7.4. Regional Market Snapshot
• 7.5. SWOT Analysis
  • 7.5.1. North America
  • 7.5.2. Europe
  • 7.5.3. Asia Pacific
  • 7.5.4. Latin America
  • 7.5.5. Middle East & Africa
• 7.6. Aerosol Drug Delivery Devices Market Share, By Region, 2024 & 2030, USD Million
• 7.7. North America
  • 7.7.1. North America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. U.S.
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Landscape/Reimbursement Scenario
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. U.S. Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Canada
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Landscape/Reimbursement Scenario
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. Mexico
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Landscape/Reimbursement Scenario
    • 7.7.4.3. Competitive Insights
    • 7.7.4.4. Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Europe
  • 7.8.1. Europe Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. UK
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Landscape/Reimbursement Scenario
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. UK Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Germany
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Landscape/Reimbursement Scenario
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Germany Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. France
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Landscape/Reimbursement Scenario
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. France Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Italy
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Landscape/Reimbursement Scenario
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Italy Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.6. Spain
    • 7.8.6.1. Key Country Dynamics
    • 7.8.6.2. Regulatory Landscape/Reimbursement Scenario
    • 7.8.6.3. Competitive Insights
    • 7.8.6.4. Spain Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.7. Sweden
    • 7.8.7.1. Key Country Dynamics
    • 7.8.7.2. Regulatory Landscape/Reimbursement Scenario
    • 7.8.7.3. Competitive Insights
    • 7.8.7.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.8. Denmark
    • 7.8.8.1. Key Country Dynamics
    • 7.8.8.2. Regulatory Landscape/Reimbursement Scenario
    • 7.8.8.3. Competitive Insights
    • 7.8.8.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.9. Norway
    • 7.8.9.1. Key Country Dynamics
    • 7.8.9.2. Regulatory Landscape/Reimbursement Scenario
    • 7.8.9.3. Competitive Insights
    • 7.8.9.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Asia Pacific
  • 7.9.1. Asia Pacific Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. China
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Landscape/Reimbursement Scenario
    • 7.9.2.3. Competitive Insights
    • 7.9.2.4. China Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Japan
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Landscape/Reimbursement Scenario
    • 7.9.3.3. Competitive Insights
    • 7.9.3.4. Japan Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. India
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Landscape/Reimbursement Scenario
    • 7.9.4.3. Competitive Insights
    • 7.9.4.4. India Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. South Korea
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Regulatory Landscape/Reimbursement Scenario
    • 7.9.5.3. Competitive Insights
    • 7.9.5.4. South Korea Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.6. Australia
    • 7.9.6.1. Key Country Dynamics
    • 7.9.6.2. Regulatory Landscape/Reimbursement Scenario
    • 7.9.6.3. Competitive Insights
    • 7.9.6.4. Australia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.7. Thailand
    • 7.9.7.1. Key Country Dynamics
    • 7.9.7.2. Regulatory Landscape/Reimbursement Scenario
    • 7.9.7.3. Competitive Insights
    • 7.9.7.4. Thailand Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.10. Latin America
  • 7.10.1. Latin America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10.2. Brazil
    • 7.10.2.1. Key Country Dynamics
    • 7.10.2.2. Regulatory Landscape/Reimbursement Scenario
    • 7.10.2.3. Competitive Insights
    • 7.10.2.4. Brazil Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10.3. Argentina
    • 7.10.3.1. Key Country Dynamics
    • 7.10.3.2. Regulatory Landscape/Reimbursement Scenario
    • 7.10.3.3. Competitive Insights
    • 7.10.3.4. Argentina Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.11. Middle East and Africa
  • 7.11.1. Middle East and Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.2. South Africa
    • 7.11.2.1. Key Country Dynamics
    • 7.11.2.2. Regulatory Landscape/Reimbursement Scenario
    • 7.11.2.3. Competitive Insights
    • 7.11.2.4. South Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.3. Saudi Arabia
    • 7.11.3.1. Key Country Dynamics
    • 7.11.3.2. Regulatory Landscape/Reimbursement Scenario
    • 7.11.3.3. Competitive Insights
    • 7.11.3.4. Saudi Arabia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.4. UAE
    • 7.11.4.1. Key Country Dynamics
    • 7.11.4.2. Regulatory Landscape/Reimbursement Scenario
    • 7.11.4.3. Competitive Insights
    • 7.11.4.4. UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.5. Kuwait
    • 7.11.5.1. Key Country Dynamics
    • 7.11.5.2. Regulatory Landscape/Reimbursement Scenario
    • 7.11.5.3. Competitive Insights
    • 7.11.5.4. UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
• 8.6. Company Profiles
  • 8.6.1. AptarGroup, Inc.
    • 8.6.1.1. Participant's Overview
    • 8.6.1.2. Financial Performance
    • 8.6.1.3. Product Benchmarking
    • 8.6.1.4. Recent Developments
  • 8.6.2. Koninklijke Philips N.V.
    • 8.6.2.1. Participant's Overview
    • 8.6.2.2. Financial Performance
    • 8.6.2.3. Product Benchmarking
    • 8.6.2.4. Recent Developments
  • 8.6.3. AstraZeneca
    • 8.6.3.1. Participant's Overview
    • 8.6.3.2. Financial Performance
    • 8.6.3.3. Product Benchmarking
    • 8.6.3.4. Recent Developments
  • 8.6.4. Novartis AG
    • 8.6.4.1. Participant's Overview
    • 8.6.4.2. Financial Performance
    • 8.6.4.3. Product Benchmarking
    • 8.6.4.4. Recent Developments
  • 8.6.5. Sanofi
    • 8.6.5.1. Participant's Overview
    • 8.6.5.2. Financial Performance
    • 8.6.5.3. Product Benchmarking
    • 8.6.5.4. Recent Developments
  • 8.6.6. OMRON Corporation
    • 8.6.6.1. Participant's Overview
    • 8.6.6.2. Financial Performance
    • 8.6.6.3. Product Benchmarking
    • 8.6.6.4. Recent Developments
  • 8.6.7. Medline Industries, LP.
    • 8.6.7.1. Participant's Overview
    • 8.6.7.2. Financial Performance
    • 8.6.7.3. Product Benchmarking
    • 8.6.7.4. Recent Developments
  • 8.6.8. GF Health Products, Inc.
    • 8.6.8.1. Participant's Overview
    • 8.6.8.2. Financial Performance
    • 8.6.8.3. Product Benchmarking
    • 8.6.8.4. Recent Developments
  • 8.6.9. DRIVE MEDICAL GMBH & CO. KG
    • 8.6.9.1. Participant's Overview
    • 8.6.9.2. Financial Performance
    • 8.6.9.3. Product Benchmarking
    • 8.6.9.4. Recent Developments
  • 8.6.10. Teva Pharmaceutical Industries Ltd
    • 8.6.10.1. Participant's Overview
    • 8.6.10.2. Financial Performance
    • 8.6.10.3. Product Benchmarking
    • 8.6.10.4. Recent Developments
  • 8.6.11. Aerogen (Stamford Devices Limited Group)
    • 8.6.11.1. Participant's Overview
    • 8.6.11.2. Financial Performance
    • 8.6.11.3. Product Benchmarking
    • 8.6.11.4. Recent Developments
  • 8.6.12. Sensirion AG
    • 8.6.12.1. Participant's Overview
    • 8.6.12.2. Financial Performance
    • 8.6.12.3. Product Benchmarking
    • 8.6.12.4. Recent Developments
  • 8.6.13. PARI Respiratory Equipment, Inc.
    • 8.6.13.1. Participant's Overview
    • 8.6.13.2. Financial Performance
    • 8.6.13.3. Product Benchmarking
    • 8.6.13.4. Recent Developments
  • 8.6.14. Catalent, Inc
    • 8.6.14.1. Participant's Overview
    • 8.6.14.2. Financial Performance
    • 8.6.14.3. Product Benchmarking
    • 8.6.14.4. Recent Developments
  • 8.6.15. Pfizer Inc.
    • 8.6.15.1. Participant's Overview
    • 8.6.15.2. Financial Performance
    • 8.6.15.3. Product Benchmarking
    • 8.6.15.4. Recent Developments
  • 8.6.16. Beurer GmbH
    • 8.6.16.1. Participant's Overview
    • 8.6.16.2. Financial Performance
    • 8.6.16.3. Product Benchmarking
    • 8.6.16.4. Recent Developments